Brinker Capital Investments’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-10,606
| Closed | -$778K | – | 1628 |
|
|
2022
Q4 | $778K | Buy |
10,606
+333
| +3% | +$24.4K | 0.02% | 818 |
|
|
2022
Q3 | $781K | Buy |
10,273
+868
| +9% | +$66K | 0.02% | 796 |
|
|
2022
Q2 | $654K | Sell |
9,405
-507
| -5% | -$35.3K | 0.01% | 878 |
|
|
2022
Q1 | $821K | Sell |
9,912
-1,248
| -11% | -$103K | 0.01% | 873 |
|
|
2021
Q4 | $838K | Sell |
11,160
-414
| -4% | -$31.1K | 0.01% | 886 |
|
|
2021
Q3 | $2.57M | Hold |
11,574
| – | – | 0.04% | 470 |
|
|
2021
Q2 | $2.57M | Buy |
11,574
+1,084
| +10% | +$240K | 0.03% | 526 |
|
|
2021
Q1 | $1.39M | Sell |
10,490
-10,402
| -50% | -$1.38M | 0.02% | 608 |
|
|
2020
Q4 | $3.62M | Buy |
20,892
+10,186
| +95% | +$1.76M | 0.06% | 403 |
|
|
2020
Q3 | $1.19M | Buy |
+10,706
| New | +$1.19M | 0.02% | 632 |
|
|
2020
Q1 | – | Sell |
-54
| Closed | -$5K | – | 604 |
|
|
2019
Q4 | $5K | Buy |
+54
| New | +$5K | ﹤0.01% | 661 |
|